Healthcare DIVE January 8, 2025
Emily Olsen

If closed, the deal will take Accolade private and create a single firm with more than 1,400 employer and payer clients.

Dive Brief:

  • Transcarent, a healthcare platform for self-insured employers, will acquire benefits navigator Accolade for about $621 million, the companies announced Wednesday.
  • The deal will combine Transcarent’s offerings — including an artificial intelligence-backed information and navigation service, health benefits guidance and virtual care — with Accolade’s services, like providing virtual primary care and specialist consultations, as well as patient advocates and care navigation.
  • The acquisition will net Accolade stockholders $7.03 per share in cash, an approximately 110% premium over the company’s closing stock price on Tuesday. Transcarent’s CEO, noted entrepreneur and investor Glen Tullman, will head...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Insurance, Mergers & Acquisitions / JV, Provider, Self-insured, Technology, Trends
The Crawl, Walk And Run: A Look At Phases Of AI In The Enterprise
Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health
What AGI hype means for Washington
Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses
Finding Six-Figure Jobs In AI: Nvidia Offers Free Training Courses

Share This Article